Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Dec 8;10:5817–5826. doi: 10.2147/OTT.S150456

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2017 Cui et al. This work is published and licensed by Dove Medical Press Limited

The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.

PMC Copyright notice

The PGE₂ and AA level and the expression of FAK in the clinical samples before and after chemotherapy.

Notes: (A) The AA and PGE₂ levels of patient plasma samples were measured by ELISA. The PGE₂-to-AA ratios of patient plasma samples before and after chemotherapy were compared. Three independent experiments were carried out. The results are expressed as the mean ± SD of three independent experiments, ^*P<0.05 compared with the control group. (B) Immunohistochemical staining of FAK and p-FAK in patient ovarian cancer samples before and after chemotherapy. (C) Levels of FAK and p-FAK were quantified according to immunohistochemical staining score.

Abbreviations: PGE₂, prostaglandin E₂; AA, arachidonic acid; FAK, focal adhesion kinase; ELISA, enzyme-linked immunosorbent assay; SD, standard deviation; p-FAK, phosphorylated FAK; IHC, immunohistochemical.